|
Volumn 1, Issue 3, 2001, Pages 301-315
|
Viral vector-mediated gene therapy for hemophilia.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
ADENO ASSOCIATED VIRUS;
ADENOVIRUS;
ANIMAL;
DOG;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HEMOPHILIA A;
HEMOPHILIA B;
HUMAN;
LENTIVIRINAE;
MOLONEY LEUKEMIA ONCOVIRUS;
MOUSE;
PHASE 1 CLINICAL TRIAL;
REVIEW;
ADENOVIRIDAE;
ANIMALS;
CLINICAL TRIALS, PHASE I;
DEPENDOVIRUS;
DOGS;
FACTOR IX;
FACTOR VIII;
GENE THERAPY;
GENETIC VECTORS;
HEMOPHILIA A;
HEMOPHILIA B;
HUMANS;
LENTIVIRUS;
MICE;
MOLONEY MURINE LEUKEMIA VIRUS;
MLCS;
MLOWN;
|
EID: 0035453311
PISSN: 15665232
EISSN: None
Source Type: Journal
DOI: 10.2174/1566523013348508 Document Type: Review |
Times cited : (21)
|
References (139)
|